No Data
He family ophthalmology (301103.SZ): Currently, the total revenue of hospitals outside the province has shown year-on-year growth, but it has not yet passed the cultivation period.
GraceLon November 20th | Heshi Ophthalmology (301103.SZ) stated in recent investor relations activities that the total revenue of hospitals outside the province has increased compared to the same period, but it has not yet passed the incubation period. When the number of outpatient services reaches a certain scale, the profit contribution of hospitals outside the province will also be significantly improved.
He Eye Hospital (301103.SZ): The company's optical business accounts for one-third of the revenue.
Gelonghui, November 20th丨He Eye Hospital (301103.SZ) recently stated in an investor relations event that the optical business accounts for one-third of the revenue, with the core products being orthokeratology lenses and defocus lenses. Due to the weak consumer market, part of the non-essential consumer demand has been delayed, leading to a year-on-year price decline.
gelonghui announcement selection | guangzhou great power energy and technology: plans to invest 5 billion yuan to build a 10GWh energy storage cell and energy storage system manufacturing plant and an independent shared energy storage research and develop
【Company Business Data】Yunda Holding (002120.SZ): In October, the revenue of express service business was 4.535 billion yuan, a year-on-year increase of 16.58%. Sto Express Co.,Ltd. (002468.SZ): In October, the revenue of express service business was 4.426 billion yuan, a year-on-year increase of 24.86%. YTO Express Group (600233.SH): In October, the revenue of express product was 5.704 billion yuan, a year-on-year increase of 26.94%. 【Project Investment】Hainan Strait Shipping (002320.SZ): Qiongzhou ferry plans to invest 0.26 billion yuan to build a green asia vets intelligent passenger ship to replace existing old ships. Hainan Strait Shipping (00
Haich Eye (301103.SZ): Not ruling out business expansion through mergers and acquisitions.
Gelonghui November 13th | Heshi Ophthalmology (301103.SZ) stated at an investor relations event that the company adheres to consumer-oriented medical global strategy, focusing on the development of optometry clinics and optometry centers, and will later carry out a combination of company-built and franchised chains, focusing on jing-jin-ji, cheng-yu urban agglomeration, cni zhujiang index, and cni yangtze index and other economically developed regions for pilot projects. At the same time, business expansion may also be carried out through mergers and acquisitions.
Ho\'s Ophthalmology: Report for the third quarter of 2024
Henshi Ophthalmology (301103.SZ): The net income in the first three quarters was 16.3755 million yuan, a year-on-year decrease of 83.53%.
GeLongHui October 28th | HaShi Ophthalmology (301103.SZ) released the third quarter report for 2024, the first three quarters of 2024, the company achieved revenue of 0.865 billion yuan, a year-on-year decrease of 8.40%; net income attributable to shareholders of the listed company was 16.3755 million yuan, a year-on-year decrease of 83.53%; net income after deducting non-recurring gains and losses was 14.7894 million yuan, a year-on-year decrease of 84.57%; basic earnings per share was 0.1045 yuan/share.
Liaoning He Eye Hospital Group (SZSE:301103) Could Be Struggling To Allocate CapitalNo Data
No Data
